302 related articles for article (PubMed ID: 23219525)
1. Influence of sildenafil and tadalafil on the enzyme- and transporter-inducing effects of bosentan and ambrisentan in LS180 cells.
Weiss J; Theile D; Spalwisz A; Burhenne J; Riedel KD; Haefeli WE
Biochem Pharmacol; 2013 Jan; 85(2):265-73. PubMed ID: 23219525
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological treatment of pulmonary hypertension at a turning point].
Watanabe H
Nihon Yakurigaku Zasshi; 2014 Apr; 143(4):165-72. PubMed ID: 24717603
[No Abstract] [Full Text] [Related]
3. Differential modulation of the expression of important drug metabolising enzymes and transporters by endothelin-1 receptor antagonists ambrisentan and bosentan in vitro.
Weiss J; Herzog M; Haefeli WE
Eur J Pharmacol; 2011 Jun; 660(2-3):298-304. PubMed ID: 21501604
[TBL] [Abstract][Full Text] [Related]
4. Desmethyl bosentan displays a similar in vitro interaction profile as bosentan.
Weiss J; Baumann S; Theile D; Haefeli WE
Pulm Pharmacol Ther; 2015 Feb; 30():80-6. PubMed ID: 25535031
[TBL] [Abstract][Full Text] [Related]
5. Plasma Drug Concentrations in Patients with Pulmonary Arterial Hypertension on Combination Treatment.
Grünig E; Ohnesorge J; Benjamin N; Burhenne J; Enderle Y; Egenlauf B; Fischer C; Harutyunova S; Huppertz A; Klose H; Haefeli WE
Respiration; 2017; 94(1):26-37. PubMed ID: 28494463
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes.
Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R
Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension.
Yokoyama Y; Tomatsuri M; Hayashi H; Hirai K; Ono Y; Yamada Y; Todoroki K; Toyo'oka T; Yamada H; Itoh K
J Pharm Biomed Anal; 2014 Feb; 89():227-32. PubMed ID: 24309556
[TBL] [Abstract][Full Text] [Related]
9. Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil.
Treiber A; Schneiter R; Häusler S; Stieger B
Drug Metab Dispos; 2007 Aug; 35(8):1400-7. PubMed ID: 17496208
[TBL] [Abstract][Full Text] [Related]
10. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
[TBL] [Abstract][Full Text] [Related]
11. Ambrisentan and tadalafil synergistically relax endothelin-induced contraction of rat pulmonary arteries.
Liang F; Yang S; Yao L; Belardinelli L; Shryock J
Hypertension; 2012 Mar; 59(3):705-11. PubMed ID: 22311911
[TBL] [Abstract][Full Text] [Related]
12. Dried Blood Spot Technique for the Monitoring of Ambrisentan, Bosentan, Sildenafil, and Tadalafil in Patients with Pulmonary Arterial Hypertension.
Enderle Y; Meid AD; Friedrich J; Grünig E; Wilkens H; Haefeli WE; Burhenne J
Anal Chem; 2015 Dec; 87(24):12112-20. PubMed ID: 26583764
[TBL] [Abstract][Full Text] [Related]
13. Bladder endothelin-1 receptor binding of bosentan and ambrisentan.
Osano A; Yokoyama Y; Hayashi H; Itoh K; Okura T; Deguchi Y; Ito Y; Yamada S
J Pharmacol Sci; 2014; 124(1):86-91. PubMed ID: 24389822
[TBL] [Abstract][Full Text] [Related]
14. Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.
Dranitsaris G; Mehta S
Appl Health Econ Health Policy; 2009; 7(1):43-59. PubMed ID: 19558194
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers.
Spence R; Mandagere A; Dufton C; Venitz J
J Clin Pharmacol; 2008 Dec; 48(12):1451-9. PubMed ID: 18832294
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of endothelin receptor antagonists combined with phosphodiesterase 5 inhibitor in the treatment of pulmonary arterial hypertension: a network meta-analysis].
Fu WH; Chen PL; Xia JL; Fu L; Shen Y; He WJ; Chen YH; Ren N; Jiang Q; Ma R; Wang T; Wang XN; Zhang NF; Liu CL
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Feb; 45(2):158-170. PubMed ID: 35135085
[No Abstract] [Full Text] [Related]
17. Combination of sildenafil and bosentan for pulmonary hypertension in a human ex vivo model.
Ried M; Potzger T; Neu R; Sziklavari Z; Szöke T; Liebold A; Hofmann HS; Hoenicka M
Cardiovasc Drugs Ther; 2014 Feb; 28(1):45-51. PubMed ID: 24193244
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension.
Montani D; Chaumais MC; Savale L; Natali D; Price LC; Jaïs X; Humbert M; Simonneau G; Sitbon O
Adv Ther; 2009 Sep; 26(9):813-25. PubMed ID: 19768639
[TBL] [Abstract][Full Text] [Related]
19. Mutual pharmacokinetic interactions between steady-state bosentan and sildenafil.
Burgess G; Hoogkamer H; Collings L; Dingemanse J
Eur J Clin Pharmacol; 2008 Jan; 64(1):43-50. PubMed ID: 18040672
[TBL] [Abstract][Full Text] [Related]
20. Superior vasodilation of human pulmonary vessels by vardenafil compared with tadalafil and sildenafil: additive effects of bosentan.
Ried M; Neu R; Lehle K; Großer C; Szöke T; Lang G; Hofmann HS; Hoenicka M
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):254-259. PubMed ID: 28486684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
